British Columbia Investment Management Corp Has $11,125,000 Position in Cardinal Health Inc. (CAH)
British Columbia Investment Management Corp lowered its position in shares of Cardinal Health Inc. (NYSE:CAH) by 13.6% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 143,181 shares of the company’s stock after selling 22,443 shares during the period. British Columbia Investment Management Corp’s holdings in Cardinal Health were worth $11,125,000 at the end of the most recent reporting period.
Several other institutional investors have also made changes to their positions in CAH. Integrated Investment Consultants LLC increased its position in shares of Cardinal Health by 15.4% in the second quarter. Integrated Investment Consultants LLC now owns 1,459 shares of the company’s stock worth $114,000 after buying an additional 195 shares in the last quarter. JFS Wealth Advisors LLC increased its stake in shares of Cardinal Health by 8,281.0% in the second quarter. JFS Wealth Advisors LLC now owns 1,760 shares of the company’s stock valued at $137,000 after buying an additional 1,739 shares during the period. Advisory Services Network LLC increased its stake in shares of Cardinal Health by 398.2% in the second quarter. Advisory Services Network LLC now owns 1,948 shares of the company’s stock valued at $152,000 after buying an additional 1,557 shares during the period. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA increased its stake in shares of Cardinal Health by 27.2% in the second quarter. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA now owns 2,480 shares of the company’s stock valued at $193,000 after buying an additional 530 shares during the period. Finally, Charlemagne Capital Ltd. increased its stake in shares of Cardinal Health by 0.4% in the second quarter. Charlemagne Capital Ltd. now owns 2,527 shares of the company’s stock valued at $196,000 after buying an additional 10 shares during the period. 88.39% of the stock is owned by institutional investors and hedge funds.
Cardinal Health Inc. (NYSE:CAH) traded up 0.79% on Friday, hitting $71.11. 1,035,562 shares of the company were exchanged. Cardinal Health Inc. has a 52 week low of $62.70 and a 52 week high of $91.23. The company has a market capitalization of $22.76 billion, a P/E ratio of 17.21 and a beta of 0.73. The firm’s 50 day moving average is $71.88 and its 200 day moving average is $77.59.
Cardinal Health (NYSE:CAH) last posted its quarterly earnings data on Monday, October 31st. The company reported $1.24 EPS for the quarter, topping the consensus estimate of $1.21 by $0.03. The firm earned $32 billion during the quarter, compared to analyst estimates of $31.12 billion. Cardinal Health had a net margin of 1.08% and a return on equity of 25.20%. Cardinal Health’s revenue was up 14.2% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.38 EPS. On average, equities research analysts forecast that Cardinal Health Inc. will post $5.47 earnings per share for the current fiscal year.
The company also recently disclosed a quarterly dividend, which will be paid on Sunday, January 15th. Investors of record on Tuesday, January 3rd will be paid a dividend of $0.4489 per share. The ex-dividend date of this dividend is Thursday, December 29th. This represents a $1.80 annualized dividend and a dividend yield of 2.53%. Cardinal Health’s dividend payout ratio (DPR) is presently 43.58%.
Several brokerages recently weighed in on CAH. Bank of America Corp. reissued a “hold” rating and set a $90.00 price target on shares of Cardinal Health in a research report on Monday, September 19th. Deutsche Bank AG raised their price target on shares of Cardinal Health from $83.00 to $89.00 and gave the company a “hold” rating in a research report on Thursday, August 4th. Leerink Swann reissued an “outperform” rating and set a $80.00 price target (down previously from $95.00) on shares of Cardinal Health in a research report on Wednesday, November 2nd. Cleveland Research downgraded shares of Cardinal Health from a “buy” rating to a “neutral” rating in a research report on Monday, October 10th. Finally, Zacks Investment Research raised shares of Cardinal Health from a “sell” rating to a “hold” rating in a research report on Monday, November 14th. Ten investment analysts have rated the stock with a hold rating, seven have issued a buy rating and one has given a strong buy rating to the stock. The company presently has a consensus rating of “Buy” and a consensus price target of $91.62.
In other Cardinal Health news, Chairman George S. Barrett sold 217,995 shares of the company’s stock in a transaction that occurred on Thursday, November 10th. The shares were sold at an average price of $71.29, for a total transaction of $15,540,863.55. Following the transaction, the chairman now owns 682,226 shares in the company, valued at approximately $48,635,891.54. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 0.94% of the company’s stock.
Cardinal Health Company Profile
Cardinal Health, Inc is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies.
Receive News & Stock Ratings for Cardinal Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health Inc. and related stocks with our FREE daily email newsletter.